FOR PRESCRIBERS & CLINICS

Your Specialty Pharmacy Partner for Nuplazid®

At Patriot Pharmacy, we support clinics and prescribers managing complex neurologic and specialty therapies. Our team helps the individuals you serve start and continue prescribed treatment with fewer access barriers.

Nuplazid® (pimavanserin) is the first and only FDA-approved medicine indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. About half of people living with Parkinson’s may experience these symptoms over the course of their disease. When you prescribe Nuplazid, specialty pharmacy coordination can help reduce delays tied to coverage, prior authorization, and ongoing refill support.

Reliable access. Provider-responsive service.

Why providers partner with Patriot for Nuplazid® support:

Critical medication access
– Specialty therapies can be slowed by insurance requirements and distribution complexity. Our team helps coordinate access so patients can start therapy when clinically appropriate.

Efficient prior authorization
– Nuplazid® often requires coverage confirmation and prior authorization. We help navigate payer requirements and keep your office updated through the process.

Care coordination
– We communicate status updates quickly so your team can close gaps in care and keep treatment moving.

Financial navigation support
– When appropriate, we help identify manufacturer support pathways and affordability resources that may apply to eligible patients.

Adherence support
– Once therapy starts, continuity matters. We support refill timing, counseling touchpoints, and follow-through for patients and caregivers.

Dedicated professional team
– Work with experienced pharmacists and support staff who understand specialty workflows, complex coverage, and provider communication.

Local, high-touch service
– As an independent North Philadelphia pharmacy, Patriot provides personalized support instead of call-center runaround.

Learn More

Benefits of Nuplazid® Specialty Pharmacy Support

Hallucinations and delusions related to Parkinson’s disease psychosis can disrupt safety, caregiver burden, and quality of life. Getting patients on the right therapy should not stall in pharmacy logistics.

As your local specialty pharmacy partner, Patriot Pharmacy works with your care team to support access, coverage navigation, and continuity for complex prescriptions like Nuplazid®.

We partner with you to:

Improve timely access to prescribed specialty therapy
Streamline prior authorizations and benefits investigation
Coordinate fulfillment and refill timing with your care plan
Support adherence and patient/caregiver counseling needs
Reduce the operational burden on your office staff

**About Nuplazid® (pimavanserin)**

Class: atypical antipsychotic

Nuplazid is the first and only FDA-approved prescription medicine specifically indicated for hallucinations and delusions
associated with Parkinson’s disease psychosis.

What Parkinson’s-related hallucinations and delusions can look like:

Seeing, hearing, or experiencing things others do not
Believing things that are not true
Non-motor symptoms that may worsen over time, but are treatable
Affect up to about half of people living with Parkinson’s over the course of their disease

Why Nuplazid®?

Designed to help reduce the frequency and/or severity of Parkinson’s-related hallucinations and delusions
Works differently from many traditional antipsychotics
Avoids the dopamine-blocking approach used by many older antipsychotics that can worsen motor symptoms

Why specialty pharmacy support helps:

Specialty/limited-distribution workflows can delay starts
Insurance authorization is often required
Coordinated refill support helps patients stay on therapy
Provider-pharmacy partnership reduces access friction for the care team

Nuplazid has a Boxed Warning regarding increased mortality in elderly patients with dementia-related psychosis. Nuplazid is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis.

Always direct clinicians to full Prescribing Information, including Boxed Warning, before prescribing decisions.

Expert Care and Support for Complex Medication Needs

Explore Our Specialty Pharmacy Services

From prior authorizations to personalized counseling, Patriot Pharmacy’s specialty services are built to support patients with chronic or complex conditions. Our streamlined process, clinical expertise, and ACHC-accredited standards help make specialty medications easier to manage for both patients and providers.

References

Acadia Pharmaceuticals Inc. (n.d.). NUPLAZID® (pimavanserin). Retrieved July 24, 2026, from https://www.nuplazid.com/

Acadia Pharmaceuticals Inc. (n.d.). NUPLAZID® (pimavanserin) for healthcare professionals. Retrieved July 24, 2026, from https://www.nuplazidhcp.com/

Acadia Pharmaceuticals Inc. (n.d.). NUPLAZID® (pimavanserin) prescribing information [PDF]. Retrieved July 24, 2026, from https://www.nuplazidhcp.com/pdf/nuplazid-prescribing-information.pdf

Acadia Pharmaceuticals Inc. (n.d.). Acadia Connect® support for healthcare providers. Retrieved July 24, 2026, from https://www.acadiaconnect.com/nuplazid/healthcare-providers/support

Parkinson’s Foundation. (n.d.). Parkinson’s Foundation. Retrieved July 24, 2026, from https://www.parkinson.org/

U.S. Food and Drug Administration. (2016). NUPLAZID (pimavanserin) tablets, for oral use [Prescribing information]. Retrieved July 24, 2026, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207318lbl.pdf

U.S. Food and Drug Administration. (2020). NUPLAZID (pimavanserin) tablets/capsules, for oral use [Prescribing information]. Retrieved July 24, 2026, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207318s010,210793s007lbl.pdf

National Institute of Neurological Disorders and Stroke. (n.d.). Parkinson’s disease. National Institutes of Health. Retrieved July 24, 2026, from https://www.ninds.nih.gov/health-information/disorders/parkinsons-disease

MedlinePlus. (n.d.). Parkinson’s disease. National Library of Medicine. Retrieved July 24, 2026, from https://medlineplus.gov/parkinsonsdisease.html